Book a Demo
Platform Overview
Features
Cardiac Amyloidosis Heart Failure Aortic Stenosis Pulmonary Hypertension Strain Stress Echocardiography
Operations
Operational Impact Deployment & Security Core Lab Solutions EHR Mining Partnerships
Tools
ROI Calculator Reimbursements Peer Comparison Regulatory Status
Library & news
Clinical Evidence News
Our Story Careers Media Kit

How to Evaluate AI Echo Platforms

Echo AI products address different parts of the workflow. Use this category-based guide to compare fully automated platforms, AI-assisted workstation tools, and single-disease solutions before evaluating vendors that best fit your clinical and operational needs.

How to Compare Echo AI Platforms

Echo AI products solve different problems. Before shortlisting, decide which of these axes matters most to your lab.

01

Workflow scope

A complete workflow (acquisition through structured reporting) versus a single-phase point tool such as acquisition guidance, automated measurements, or decision support. These are not interchangeable.

02

Automation level

Fully automated vs. AI-assisted with click-by-click approval. Determines who carries the time burden.

03

Vendor neutrality

Multi-vendor DICOM intake or locked to a single OEM ultrasound stack. Affects portability and procurement leverage.

04

Disease detection

Which conditions are screened (HFpEF, amyloidosis, AS, pulmonary HTN, etc.) and whether detection is built in or sold as add-on modules.

05

Regulatory scope

FDA 510(k) clearance, CE marking, and the specific indications cleared. Different products have different cleared use cases.

06

Deployment

Cloud, on-prem, or embedded in an OEM workstation. Drives integration effort with your PACS, CVIS, and EMR.

07

Clinical validation

Peer-reviewed studies, prospective trials, and real-world deployments. The strongest evidence is reproducible across patient populations.

Category Comparison Matrix

How the four common product categories behave on the axes most echo labs care about. Pick the categories worth shortlisting before benchmarking specific vendor products.

Comparison axis
Us2.ai Fully automated platform
AI-assisted workstation Reader-driven analytics
Single-disease scoring Per-indication module
Manual workflow Current standard of care
Workflow scope
Us2.ai Complete echo workflow: measurements, disease detection, structured report
AI-assisted workstation Measurements + workstation analytics, surfaced inside the OEM reading environment
Single-disease scoring Disease-probability score for a specific cleared indication
Manual workflow Reader-driven measurements, interpretation, and structured report composition
Automation level
Us2.ai Fully automated. DICOM in, structured report out, zero clicks
AI-assisted workstation AI suggests; reader steps through and approves each measurement
Single-disease scoring Automated for the cleared indication only (single-clip workflow)
Manual workflow 100% reader-driven, click-by-click
Vendor neutrality
Us2.ai Multi-vendor DICOM: GE, Philips, Siemens, Canon, handheld POCUS
AI-assisted workstation Often embedded in or paired with a single OEM ultrasound workstation
Single-disease scoring Typically multi-vendor DICOM
Manual workflow Tied to the cart and reading workstation in front of the reader
Disease detection
Us2.ai Amyloidosis, AS, HF (HFpEF), pulmonary HTN, GLS, stress echo — bundled
AI-assisted workstation Not the primary positioning; reader makes the call
Single-disease scoring One disease per product (e.g., HFpEF, amyloidosis), sold as add-on modules
Manual workflow None — reader interprets findings against guidelines
Modalities / scope
Us2.ai All chambers, valves, Doppler, strain, stress
AI-assisted workstation Full workstation scope, AI-augmented for measurements and strain
Single-disease scoring Minimal input (often a single apical clip) per disease module
Manual workflow Full echo, every parameter reader-driven
Regulatory
Us2.ai FDA 510(k) cleared (v1 2021, v2 2024); CE Class IIb; 28+ market approvals
AI-assisted workstation Cleared/marked per-module; varies by vendor and feature set
Single-disease scoring FDA-cleared per indication; scope and cleared use cases vary by product
Manual workflow Built on existing clinical workflow; no AI clearance required
Deployment
Us2.ai Cloud or on-prem; PACS / CVIS / EMR integration via DICOM, HL7, FHIR
AI-assisted workstation On-prem / hospital server, typically inside the OEM workstation
Single-disease scoring Typically cloud, with DICOM routing
Manual workflow Reader workstation tied to the cart
Time-per-study
Us2.ai Seconds per report
AI-assisted workstation Reader pace; AI assists but does not replace the reading loop
Single-disease scoring Minutes per study for the cleared indication
Manual workflow Industry baseline of 30–45 minutes per study

Last reviewed May 2026. Category descriptions are summaries of what each product type typically does, not statements about any specific vendor product. Spot something out of date or inaccurate? Tell us and we'll review and update. FDA and CE designations belong to the respective regulatory bodies.

One Pipeline, Every Workflow Phase

Most AI echo products are point tools that solve a single phase of the workflow. Us2.ai delivers the entire echo workflow in one automated pipeline.

01

Image acquisition

Typical AI tool

Real-time AI guidance for sonographers during the scan.

Us2.ai

Vendor-neutral DICOM intake. Existing acquisition workflows are unchanged, regardless of cart or POCUS device.

02

Automated measurements

Typical AI tool

AI-assisted modules inside a workstation. Reader still steps through and approves each measurement.

Us2.ai

Fully automated across all chambers, valves, Doppler, and strain. Zero clicks per study.

03

Disease detection

Typical AI tool

Per-disease scoring products, sold as separate modules for one indication at a time.

Us2.ai

Bundled detection in the same pipeline: amyloidosis, HFpEF, AS, pulmonary HTN, GLS, stress.

04

Structured reporting

Typical AI tool

Reader-driven workstation flow. Measurements feed a template the cardiologist still composes.

Us2.ai

Structured echo report out automatically, ready for editing and sign-off.

05

Integration & deployment

Typical AI tool

Cloud-only services or stacks tied to a single OEM workstation.

Us2.ai

Cloud or on-premise, with PACS, CVIS, and EMR integration. Vendor-neutral by design.

Common Buyer Questions

If your question isn't here, contact us and we'll answer in writing.

What is the difference between fully automated echo AI and AI-assisted workstation tools?
A fully automated platform takes a DICOM study in and returns a complete structured echo report — measurements across all chambers, valvular assessment, Doppler, strain, and disease detection — with zero clicks. AI-assisted workstation tools embed AI inside an OEM reading environment to suggest measurements or surface findings, but the cardiologist still drives the click-by-click reporting loop. Us2.ai is positioned in the fully automated category.
How does Us2.ai differ from single-disease scoring tools?
Single-disease scoring tools (e.g., FDA-cleared HFpEF or amyloidosis screeners) take a minimal input — often a single apical clip — and return a probability score for the one cleared indication. Us2.ai instead produces a complete structured echo report on every study, with disease detection bundled into the same pipeline as the routine measurements. A disease-scoring tool is an additive layer; Us2.ai is positioned as the analysis layer itself.
What is the regulatory landscape for AI echocardiography software?
AI echocardiography products are FDA 510(k) cleared, CE marked, and/or registered in additional markets per indication. Cleared use cases vary widely — some products are cleared for automated measurements, others for a specific disease score, others for acquisition guidance. Always check each product’s 510(k) summary or CE technical file for the exact cleared indications. Us2.ai is FDA 510(k) cleared (v1 2021, v2 2024), CE Class IIb, and approved in 28+ markets.
Does Us2.ai work with GE, Philips, Siemens, and Canon ultrasound machines?
Yes. Us2.ai operates on standard DICOM and is vendor-neutral. It analyzes images acquired on every major cart-based ultrasound platform and on handheld POCUS devices. Products embedded inside a specific OEM workstation are generally limited to that vendor’s ecosystem.
How does AI echocardiography compare to manual reporting?
Manual reporting today involves a sonographer or cardiologist clicking through every measurement, then composing a structured report — commonly 30–45 minutes per study. Fully automated AI returns a complete structured report in seconds; AI-assisted workstation tools shorten parts of the loop but keep the reader in the driver’s seat for the report itself.
Cloud vs on-premise: which deployment model fits hospital IT?
Both are widely used in echo AI. Cloud deployments minimize on-site infrastructure and roll out updates automatically; on-premise keeps DICOM traffic inside the hospital network and is preferred where data residency or air-gapped environments are required. Us2.ai supports both, with PACS / CVIS / EMR integration via DICOM, HL7, and FHIR. Some echo AI products are cloud-only; some are tied to vendor workstations.
How long does a fully automated echo analysis take?
A fully automated platform returns a structured report in seconds per study once DICOM images are received. AI-assisted tools shorten parts of the read but still run at reader pace. Single-disease scoring tools typically return their result in minutes for the cleared indication. Running a head-to-head pilot on your own studies is the only reliable way to compare end-to-end turnaround in your lab.
Is Us2.ai FDA cleared?
Yes — Us2.ai is FDA 510(k) cleared (v1 2021, v2 2024), CE Class IIb marked, and approved in 28+ regulatory markets including the US, EU, UK, Canada, Australia, Singapore, and Japan. See the platform overview for the current list of cleared indications.

See Us2.ai in Your Lab

The fastest way to compare is on your own studies. We'll run a head-to-head pilot with your DICOM data and your reporting workflow.